首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1289775

全球心臟病發作診斷市場 - 2023-2030年

Global Heart Attack Diagnostics Market - 2023-2030

出版日期: 2023年06月12日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球心臟病診斷市場在2022年達到87.446億美元，預計到2030年將見證有利可圖的成長，達到156.053億美元。在預測期間（2023-2030年），全球心臟病診斷市場預計將呈現7.7%的複合年成長率。

全球心臟病診斷市場受到許多變量的影響，包括飲食習慣、環境暴露和遺傳易感性。這些因素可以通過引起高血壓、高膽固醇、肥胖和糖尿病而增加心血管疾病的風險。

心臟病發作也在很大程度上受到不健康習慣的影響，包括吸煙、喝太多的酒和吃很多快餐。由於採用了這些有害的習慣，人口中心臟病發作的流行率增加。

市場動態

採用新產品發布中使用的重要措施

心臟病發作診斷法市場的擴張正受到各種因素的推動，包括醫療保健支出的增加，領先企業之間的伙伴關係和合作，以及研發的增加。

例如，2022年11月，美國最大的虛擬第一心血管公司Heartbeat Health和開發心臟疾病新護理標準的初創公司Cleerly宣布合作，採用精準的心臟健康，更精確地評估心血管風險，提供更好的心臟護理。由於Cleerly的人工智慧分析冠狀動脈電腦斷層掃描（CCTA）的方法，醫生可以更快識別、描述和測量心臟動脈壁的動脈粥樣硬化（斑塊堆積）。

此外，在2022年11月，CardioSignal和OMRON Healthcare（一家製造和銷售自動化部件、設備和系統的公司）聯手，通過向醫生提供早期心血管疾病檢測方面的突破，為處於人口健康管理前沿的醫生提供服務。

這兩家企業將合作開發數位健康解決方案，以加強生活方式慢性病的工作流程，特別是對心血管疾病的初級護理識別。主要參與者的戰略以這樣的方式來推動市場的發展。

缺少熟練的勞動力將阻礙市場的發展

由於心導管手術是一項具有挑戰性的治療，需要高度的精確性和準確性，因此需要一個高度認證、熟練和有經驗的醫療專家團隊來進行有效的心導管手術。

預計在整個預測期內，市場的擴張將在一定程度上受到缺乏熟練的專家來進行冠狀動脈造影的限制，特別是在新興國家，由於缺乏全面的培訓計劃。

COVID-19影響分析

SARS-CoV-2病毒的流行促使了全球封鎖，對心臟病的診斷產生了災難性的影響。有心臟疾病的人更容易感染病毒，特別是那些容易發生心臟病的人，如果不能及早發現感染，他們很有可能會死亡。

此外，由於缺乏及時診斷，人們對心血管健康結果的長期惡化有很大擔憂。在病人獲得心血管診斷和治療的過程中，並沒有很多不同的參與方。

俄烏戰爭影響分析

由於俄羅斯-烏克蘭在該地區沒有關鍵的市場參與者，估計對全球心臟病診斷市場的影響很小。然而，在預測期內，原料、測試產品和設備的進出口的影響預計對全球心臟病診斷市場的影響很小。

人工智慧影響分析

人工智慧預計將對全球心臟病診斷市場產生積極的影響。因為人工智慧算法可以分析大量的病人數據，包括醫療記錄、實驗室結果、成像掃描和遺傳資訊。通過處理這些數據，人工智慧可以識別人類醫生可能沒有註意到的模式和細微指標，從而對心臟病發作進行更準確和可靠的診斷。

人工智慧算法可以即時分析數據，提供快速和準確的心臟病發作診斷。這在時間緊迫的緊急情況下可能特別有用，使醫生能夠迅速開始適當的治療。

Market Overview

The Global Heart Attack Diagnostics Market reached US$ 8,744.6 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 15,605.3 million by 2030. The global heart attack diagnostics market is expected to exhibit a CAGR of 7.7% during the forecast period (2023-2030).

The global heart attack diagnostics market is influenced by a number of variables, including dietary habits, environmental exposures, and genetic susceptibility. These elements can increase the risk of cardiovascular disease by causing high blood pressure, high cholesterol, obesity, and diabetes.

Heart attacks also are greatly influenced by unhealthy habits including smoking, drinking too much alcohol, and eating a lot of fast food. The prevalence of heart attacks among the population has increased as a result of the adoption of these harmful habits.

Market Dynamics

Adoption of Important Measures Used in New Product Launches

Heart attack diagnostics market expansion is being fueled by elements including rising healthcare spending, partnerships and collaborations between leading players, and increased R&D.

For instance, in November 2022, Heartbeat Health, the nation's largest virtual-first cardiovascular company, and Cleerly, the startup developing a new standard of care for heart illness, announced a partnership to employ precision heart health to more precisely evaluate cardiovascular risk and provide better heart care. Physicians may more quickly recognize, describe, and measure atherosclerosis (plaque buildup) in the walls of heart arteries thanks to Cleerly's AI-enabled approach for analyzing coronary computed tomography angiography (CCTA).

Additionally, in November 2022, CardioSignal and OMRON Healthcare, a manufacturing and sales of automation components, equipment and systems company, joined forces to serve doctors at the forefront of population health management by delivering breakthroughs in early cardiovascular disease detection to them.

The two businesses will work together to develop digital health solutions that enhance workflow procedures for lifestyle chronic diseases, particularly for the primary care identification of cardiovascular disease. Key players' strategies serve to propel the market in such a manner.

Lack of a Skilled Workforce will Hamper the Market Growth

A team of highly certified, skilled, and experienced healthcare experts is needed to carry out an efficient cardiac catheterization operation because it is a challenging treatment that demands a high level of precision and accuracy.

It is anticipated that throughout the projection period, market expansion will be somewhat constrained by a dearth of skilled specialists to perform coronary angiograms, particularly in emerging nations due to the absence of comprehensive training programs.

COVID-19 Impact Analysis

The SARS-CoV-2 virus epidemic led to a global lockdown and had a disastrous impact on heart attack diagnosis. People with heart conditions are more likely to develop the virus, especially those who are prone to heart attacks, and if the infection is not identified early enough, there is a high likelihood that they will die.

Additionally, there are significant worries regarding the long-term deterioration of cardiovascular health outcomes as a result of a lack of prompt diagnosis. There aren't many different parties involved in patient access to cardiovascular diagnosis and treatment.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global heart attack diagnostics market owing to the absence of key market players in this region. However, the impact of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global heart attack diagnostics market in the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact the global heart attack diagnostics market positively. Because AI algorithms can analyze vast amounts of patient data, including medical records, lab results, imaging scans, and genetic information. By processing this data, AI can identify patterns and subtle indicators that may go unnoticed by human physicians, leading to more accurate and reliable diagnoses of heart attacks.

AI algorithms can analyze data in real-time, providing rapid and accurate diagnosis of heart attacks. This can be particularly useful in emergency situations where time is critical, allowing doctors to quickly begin appropriate treatment

Segment Analysis

The global heart attack diagnostics market is segmented based on test type, end-user, and region.

The Electrocardiogram Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period

The electrocardiogram segment holds about 47.5% of the total heart attack diagnostics market in the forecast period. ECG gathers crucial data on the general health and performance of the heart by measuring and documenting the electrical signals the heart produces as it contracts and relaxes. Additionally, the segment is growing as a result of the leading companies' product launches and technological improvements.

For instance, in September 2020, AliveCor, a personal electrocardiogram (ECG) technology business with US FDA clearance, made its entry into the Indian market with the release of KardiaMobile 6L, a clinically-validated personal ECG device. The personal ECG device is the only six-lead, FDA-approved personal ECG device available in the world. Atrial fibrillation (AFib), bradycardia, and tachycardia, the three most prevalent arrhythmias or abnormal heartbeats, can all be found using this device.

Geographical Analysis

Europe is Estimated To Hold the Second-largest Share Of The Global Heart Attack Diagnostics Market During The Forecast Period.

The Europe region holds the second largest share of the global heart attack diagnostics market accounting for approximately 32.1% in the forecast period.

Due to a constant increase in the number of patients with CAD and peripheral artery disorders, the market for global heart attack diagnostics is continuously witnessing growth. According to results made available by the European Union in March 2022, heart attacks were a significant cause of fatalities in the EU.

Additionally, technical developments are enabling portable characteristics in testing equipment, supporting the expansion of the market's revenue. In order to diagnose heart attacks and raise blood levels of MyC rather than troponin to rapidly rule out the possibility of heart attacks in patients, Kings College London created a novel blood test gadget.

Competitive Landscape

The major global players in the market include: F Hoffmann-La Roche Ltd, Hitachi Medical Systems, GE Healthcare, Schiller AG, Siemens Healthineers, HeartFlow, Beckman Coulter, Inc., Medtronic, Cardio Diagnostics Holdings Inc, and Midmark Corporation, among others.

Why Purchase the Report?

To visualize the global heart attack diagnostics market segmentation based on product, application, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of heart attack diagnostics market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global heart attack diagnostics market report would provide approximately 53 tables,54 figures, and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Test Type
3.2. Snippet by End User
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The high prevalence of cardiovascular diseases is expected to drive the market
  - 4.1.1.2. Technological advancements in heart attack diagnostics devices
- 4.1.2. Restraints
  - 4.1.2.1. Lack of skilled workforce will hamper the market growth
- 4.1.3. Opportunity
  - 4.1.3.1. The development of more sophisticated imaging techniques, such as cardiac MRI
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Epidemiology Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Impact Analysis

9. By Test Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 9.1.2. Market Attractiveness Index, By Test Type
9.2. Electrocardiogram
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Blood Tests
9.4. Angiogram
9.5. Computerized Cardiac Tomography
9.6. Magnetic Resonance Imaging (MRI)
9.7. Others

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
- 10.1.3. Hospitals
- 10.1.4. Introduction
- 10.1.5. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.2. Ambulatory Surgical Centers
10.3. Diagnostics Centers
10.4. Cardiac Centers
10.5. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.5.1. The U.S.
  - 11.2.5.2. Canada
  - 11.2.5.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.5.1. Germany
  - 11.3.5.2. The U.K.
  - 11.3.5.3. France
  - 11.3.5.4. Italy
  - 11.3.5.5. Spain
  - 11.3.5.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.5.1. Brazil
  - 11.4.5.2. Argentina
  - 11.4.5.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.5.1. China
  - 11.5.5.2. India
  - 11.5.5.3. Japan
  - 11.5.5.4. Australia
  - 11.5.5.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. F Hoffmann-La Roche Ltd
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Hitachi Medical Systems
13.3. GE Healthcare
13.4. Schiller AG
13.5. Siemens Healthineers
13.6. HeartFlow
13.7. Beckman Coulter, Inc.
13.8. Medtronic
13.9. Cardio Diagnostics Holdings Inc
13.10. Midmark Corporation.

LIST NOT EXHAUSTIVE